Skip to main content
The William Harvey Research Institute - Faculty of Medicine and Dentistry

TH17 Responses Evaluated in RA Patients on Inhibitors of TNFα (Therapist)

[ISRCTN reference: ISRCTN 18262002] [NIHR CRN Portfolio Study ID: 18893] 

Status: Closed to recruitment

Preliminary data suggest that up-regulation of IL-17 and the Th17 pathway occurs in patients with rheumatoid arthritis (RA) who have been treated with anti-tumor necrosis factor-alpha (anti-TNFα) therapy but demonstrate an incomplete clinical response. A deeper understanding of this is required in order to determine whether IL-17 or the Th17 pathway is a valid target for intervention in this population to improve response outcomes.

The main aim of this study was to examine the relationship of IL-17 expression within blood and synovium of subjects with RA as relates to clinical response or non-response to anti-TNF therapy.  Clinical assessments, ultrasound assessments, synovial tissue bio-markers obtained from the ultrasound-guided synovial biopsy, and study-specific blood sampling are being used to evaluate the pattern of activity shown in the Th17 pathway. Recruitment of 60 patients took place in 10 NHS Trusts.

Therapist Bio & Data-Resource Metrics

Biological samples (tissue & fluids) were collected at five timepoints over a 24-week period and are linked to stringent clinical outcome measures. 60 patients were enrolled in this study, with 27 baseline and 20 follow-up synovial tissue biopsies collected.  Blood samples have been collected for 280 time-points and include wholeblood, serum, peripheral blood mononuclear cells (PBMCs), and DNA. In addition, urine was collected at four timepoints.

Further information

Supported by NIHR Barts Biomedical Research Centre



Back to top